Get started
Author

Minna Lehto

Observed name: Lehto, Minna
ORCID: 0000-0003-3811-9640
Observed ORCID: 0000-0003-3811-9640
OpenAlex ID: A5011082269
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2021 · Disha Malani, Ashwini Kumar, et al. · Cancer Discovery · 202
PDF
Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group
2012 · Riikka Räty, Tuomo Honkanen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 18
Wcn26-3140 Prospective Study on Daratumumab With or Without Autologous Stem Cell Transplantation for the Treatment of Monoclonal Gammopathy of Renal Significance (mgrs) Diseases
2026 · Minna Seppälä, Marja Kovala, et al. · Kidney International Reports
PDF
Supplementary Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2025 · Disha Malani, Ashwini Kumar, et al.
Supplementary Tables from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2025 · Disha Malani, Ashwini Kumar, et al.
Supplementary Figures from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2025 · Disha Malani, Ashwini Kumar, et al.
Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2023 · Disha Malani, Ashwini Kumar, et al.
Supplementary Tables from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2023 · Disha Malani, Ashwini Kumar, et al.
Supplementary Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2023 · Disha Malani, Ashwini Kumar, et al.
Supplementary Figures from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
2023 · Disha Malani, Ashwini Kumar, et al.
Dataset for "Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia"
2022 · Disha, Malani, Kumar, Ashwini, et al. · Zenodo (CERN European Organization for Nuclear Research)
Kun hemoglobiinipitoisuus on suurentunut
2022 · Lehto, Minna · Työväentutkimus Vuosikirja
PDF
Kohtauksittainen yöllinen hemoglobiinivirtsaisuus (PNH)
2017 · Eva-Stina Korkama, Hanna Jarva, et al. · Työväentutkimus Vuosikirja
PDF
Rituximab Maintenance Bimonthly for Two Years after Prolonged Immunochemotherapy in Elderly Patients with Mantle Cell Lymphoma (MCL) Results in Long Remissions: Update with Six-Year Follow-up of a Prospective Study By the Finnish Lymphoma Group
2014 · Riikka Räty, Tuomo Honkanen, et al. · Blood
Elderly Patients with Mantle Cell Lymphoma (MCL) – Efficacy and Feasibility of Prolonged Immunochemotherapy with Rituximab, Cytarabine and Fludarabine Added to CHOP and Followed by Rituximab Maintenance Treatment. A Prospective Study by the Finnish Lymphoma Group
2008 · Erkki Elonen, Riikka Räty, et al. · Blood
Works count: 16
Citation count: 220
H-index: 2
I10-index: 2
Year
Topic
Type